切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2015, Vol. 09 ›› Issue (01) : 58 -61. doi: 10.3877/cma.j.issn.1674-0793.2015.01.015

所属专题: 文献

综述

股腘动脉支架断裂的研究进展
郭宝磊1, 郭大乔1, 符伟国1,()   
  1. 1. 200032 上海,复旦大学附属中山医院血管外科复旦大学血管外科研究所
  • 收稿日期:2014-12-16 出版日期:2015-02-01
  • 通信作者: 符伟国

Progress of stent fracture in the femoral and popliteal arteries

Baolei Guo1, Daqiao Guo1, Weiguo Fu1,()   

  1. 1. Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
  • Received:2014-12-16 Published:2015-02-01
  • Corresponding author: Weiguo Fu
  • About author:
    Corresponding author: Fu Weiguo, Email:
引用本文:

郭宝磊, 郭大乔, 符伟国. 股腘动脉支架断裂的研究进展[J]. 中华普通外科学文献(电子版), 2015, 09(01): 58-61.

Baolei Guo, Daqiao Guo, Weiguo Fu. Progress of stent fracture in the femoral and popliteal arteries[J]. Chinese Archives of General Surgery(Electronic Edition), 2015, 09(01): 58-61.

血管腔内治疗已成为下肢动脉硬化性闭塞症的一线治疗。随着腔内技术进步和支架材料改进,股腘动脉段严重狭窄和闭塞病变植入支架治疗也已取得较满意疗效,研究表明支架断裂可导致支架内再狭窄,并显著影响支架通畅率。本文就目前股腘动脉段支架断裂的现状和处理策略作一综述。

Endovascular treatment has been the first-line therapeutic strategy for arteriosclerosis obliterans. With the advancement of endovascular procedure and improvement of stent material, stent repair of severe stenosis and occlusion in femoral and popliteal arteries is satisfying. However, studies have demonstrated that stent fracture can induce the tough issue of in-stent restenosis, which would influence the primary patency. The current research progress and strategy of stent fracture in the femoral and popliteal arteries are reviewed.

[1]
Duda SH,Pusich B,Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: sixmonth results[J]. Circulation, 2002, 106(12): 1505-1509.
[2]
Rits J,van Herwaarden JA,Jahrome AK, et al. The incidence of arterial stent fractures with exclusion of coronary, aortic, and non-arterial settings[J]. Eur J Vasc Endovasc Surg, 2008, 36(3): 339-345.
[3]
Laird JR,Katzen BT,Scheinert D, et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial[J]. J Endovasc Ther, 2012, 19(1): 1-9.
[4]
Suzuki K,Iida O,Soga Y, et al. Long-term results of the S.M.A.R.T. Control (TM) stent for superficial femoral artery lesions, J- SMART registry[J]. Circ J, 2011, 75(4): 939-944.
[5]
Schillinger M,Sabeti S,Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery[J]. New Engl J Med, 2006, 354(18): 1879-1888.
[6]
Davaine JM,Quérat J,Guyomarch B, et al. Incidence and the clinical impact of stent fractures after primary stenting for TASC C and D femoropopliteal lesions at 1 year[J]. Eur J Vasc Endovasc Surg, 2013,46(2):201-212.
[7]
Krankenberg H,Schlueter M,Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)[J]. Circulation, 2007, 116(3): 285-292.
[8]
Karnabatidis D,Katsanos K,Spiliiopoulos S, et al. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents[J]. J Endovasc Ther, 2009, 16(1): 15-22.
[9]
Allie D,Herbert C,Walker C. Nitinol stent fractures in the SFA[J]. Endovasc Today, 2004, 3: 22-34.
[10]
Jaff M,Dake M,Pornpa J, et al. Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices[J]. Catheter Cardio Inte,2007, 70(3): 460-462.
[11]
Doi H,Maehara A,Mintz GS, et al. Intravascular ultrasound findings of stent fractures in patients with Sirolimus-and Paclitaxeleluting stents[J]. Am J Cardiol, 2010, 106(7): 952-957.
[12]
Adlakha S,Sheikh M,Wu J, et al. Stent fracture in the coronary and peripheral arteries[J]. J Interv Cardiol, 2010, 23(4): 411-419.
[13]
Watanabe T,Tamura A,Miyamoto K, et al. Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture[J]. Int J Cardiol, 2010, 140(1): e12-13.
[14]
Nikanorov A,Smouse HB,Osman K, et al. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions[J]. J Vasc Surg, 2008, 48(2): 435-440.
[15]
Laird JR,Katzen BT,Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery twelve-month results from the RESILIENT randomized trial[J]. CircCardiovasc Interv, 2010, 3(3): 267-276.
[16]
Schlager O,Dick P,Sabeti S, et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures[J]. J Endovasc Ther, 2005, 12(6): 676-684.
[17]
Bates MC,Campbell JR,Campbell JE. Late complication of stent fragmentation related to the "lever-arm effect"[J]. J Endovasc Ther, 2008, 15(2): 224-230.
[18]
Cheng CP,Wilson NM,Hallett RL, et al. In vivo MR angiographic quantification of axial and twisting deformations of the superficial femoral artery resulting from maximum hip and knee flexion[J]. J Vasc Interv Radiol, 2006, 17(6): 979-987.
[19]
Scheinert D,Scheinert S,Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting[J]. J Am Coll Cardiol, 2005, 45(2): 312-315.
[20]
Otsuka F,Nakano M,Sakakura K, et al. Unique demands of the femoral anatomy and pathology and the need for unique interventions[J]. J Cardiovasc Surg, 2013, 54(2): 191-210.
[21]
Iida O,Nanto S,Uematsu M, et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery[J]. Am J Cardiol, 2006, 98(2): 272-274.
[22]
Adlakha S,Sheikh M,Wu J, et al. Stent fracture in the coronary and peripheral arteries[J]. J Interv Cardiol, 2010, 23(4): 411-419.
[23]
Tosaka A,Soga Y,Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting[J]. J Am Coll Cardiol, 2012, 59(1): 16-23.
[24]
Bosiers M,Deloose K,Keirs EK, et al. Prevention and treatment of in-stent restenosis[J]. J Cardiovasc Surg, 2010, 51(4): 591-598.
[25]
Higashiura W,Sakaguchi S,Morimoto K, et al. Stent fracture and reocclusion after placement of a single self-expanding stent in the common iliac artery and endovascular treatment[J]. Cardiovasc Inter Radiol, 2008, 31(5): 1013-1017.
[1] 戴云, 徐超丽, 林秀玉, 孙晖, 李娟, 宋秋怡, 王晓春, 杨斌. 超声造影评价移植肾动脉狭窄支架治疗短期疗效的临床价值[J]. 中华医学超声杂志(电子版), 2023, 20(03): 301-306.
[2] 郭璐琦, 赵雅琦, 李霁欣, 周兰, 林金鹏, 张子砚, 李俊杰, 王少白. 免荷矫形器对膝骨关节炎的生物力学影响的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(04): 560-565.
[3] 刘虹宏, 杨永红, 张冬花, 林运. 老年冠脉分叉病变主支支架植入后在损伤边支使用药物涂层球囊进行修复的临床研究[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 387-393.
[4] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[5] 钟文文, 李科, 刘碧好, 蔡炳, 脱颖, 叶雷, 马波, 瞿虎, 汪中扬, 王德娟, 邱剑光. 不同比例聚乳酸/丝素蛋白复合支架在兔尿道缺损修复中的疗效[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 516-522.
[6] 张翼飞, 郭强, 赖华健, 钟文文, 叶雷, 马波, 瞿虎, 尧冰, 邱剑光, 王德娟. 加速康复外科在儿童尿道下裂围术期的应用效果分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 367-371.
[7] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[8] 曹玲, 张业坡, 袁珊珊, 胡红杰, 余日胜. 恶性胆道梗阻行胆道支架置入术后危重并发症及其危险因素研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(04): 203-210.
[9] 吴佳霖, 罗骏阳, 钟胜, 王有枝, 姜在波. 肝内小直径覆膜支架联合抽栓、溶栓治疗门静脉血栓二例[J]. 中华介入放射学电子杂志, 2023, 11(04): 377-379.
[10] 许少睿, 孔杰, 马骏, 尚金林, 苏浩波. 西门子Artis Zee系列神经介入术专属透视策略的创建与应用[J]. 中华介入放射学电子杂志, 2023, 11(04): 318-323.
[11] 霍小森, 刘言, 董延妍, 边灵杰, 李媛, 李磊, 安鹏, 王洪武. 双支架联合治疗晚期肺癌致中心气道狭窄及上腔静脉综合征一例[J]. 中华介入放射学电子杂志, 2023, 11(03): 292-294.
[12] 杨伟洪, 向先俊, 郭宗锦, 王亮, 周汝明, 魏民新, 王赞鑫. 主动脉夹层累及腹腔分支二期腔内治疗的中期研究[J]. 中华介入放射学电子杂志, 2023, 11(03): 236-240.
[13] 袁畅, 李志刚. 胸部恶性肿瘤相关气管食管瘘的诊治进展[J]. 中华胸部外科电子杂志, 2023, 10(04): 241-246.
[14] 陆东生, 桂建康, 范衍, 刘春林, 李祉岑, 宫崧峰. 复合手术治疗椎动脉慢性闭塞一例[J]. 中华脑血管病杂志(电子版), 2023, 17(04): 386-393.
[15] 黎力梦, 陶悦, 刘坚军, 李旭, 王晓俊, 汪涛, 陈斌, 范隆华. 血小板抑制不足与颈动脉支架植入术后不良事件的相关性研究[J]. 中华脑血管病杂志(电子版), 2023, 17(03): 227-231.
阅读次数
全文


摘要